CA1322961C - Oral composition - Google Patents
Oral compositionInfo
- Publication number
- CA1322961C CA1322961C CA000547991A CA547991A CA1322961C CA 1322961 C CA1322961 C CA 1322961C CA 000547991 A CA000547991 A CA 000547991A CA 547991 A CA547991 A CA 547991A CA 1322961 C CA1322961 C CA 1322961C
- Authority
- CA
- Canada
- Prior art keywords
- fluoride
- calcium
- ions
- compositions
- mouth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
Abstract
ABSTRACT
An oral hygiene product especially for inhibiting caries is the form of toothpaste or mouthwash. The product maintains a low fluoride ion concentration in the mouth for longer periods than conventional products by the rapid precipitation of calcium fluoride either in the mouth or immediately prior to use. The product comprises a composition containing calcium ions and a further composition containing fluoride ions. The ion product of the calcium and fluoride ions of the combined product preferably exceeds 3x10-8 mol3 dm-9.
An oral hygiene product especially for inhibiting caries is the form of toothpaste or mouthwash. The product maintains a low fluoride ion concentration in the mouth for longer periods than conventional products by the rapid precipitation of calcium fluoride either in the mouth or immediately prior to use. The product comprises a composition containing calcium ions and a further composition containing fluoride ions. The ion product of the calcium and fluoride ions of the combined product preferably exceeds 3x10-8 mol3 dm-9.
Description
ORAL PRODUCTS
This invention relates to oral products, more particularly oral hygiene products which are effective to combat dental caries.
It is well known to include water-soluble fluorine-containing salts, for example sodium fluoride or sodium monofluorophosphate, in oral products, especially mouthwashes and toothpastes, and that by regular use of such products the incidence of dental caries can be reduced. It is believed that the fluoride ion or monofluorophosphate ion, interacts with the tooth substance to increase its resistance to acid attack and to aid repair of carious enamel. However, the opportunity for this efficacious interaction to occur is short-lived because the oral fluoride level falls off rapidly after use of a mouthwash or toothpaste.
There have been attempts in the past to provide means for maintaining a certain concentration of fluoride ions in ~322961 - 2 - J.3049 the mouth over a longer period. These have included proposals for locating a fluoride ion source in the mouth, for example as part of an orthodontic appliance.
The Applicants have investigated the possibility of depositing particles of a fluoride ion-releasing material in the mouth and have discovered that surprising results are achieved through the use of particles of freshly precipitated calcium fluoride, as is more particularly described hereinafter.
It is already known to treat teeth to provide anticaries protection with compositions containing calcium ions and fluoride ions. Such compositions are described in EP-A-89 136 (Procter & Gamble) and they comprise a calcium ion source, a fluoride ion source and a calcium sequestering agent possessing specific solubility and binding properties to control the precipitation of calcium fluoride. The calcium-sequestering agent present in these compositions has a stability constant sufficient to inhibit uncontrolled and rapid precipitation of calcium fluoride.
In US-A-4 080 440 (DiGuilo et al) there is described a two-part product for example mouthwash or toothpaste, for remineralising demineralised tooth enamel, consisting of a first solution containing calcium ions and a second solution containing phosphate ions and optionally fluoride ions, which solutions when mixed together form a metastable solution having a pH of about 4 or below. The metastable solution is applied to the tooth surface within 5 minutes of its formation. The ions diffuse into the demineralised subsurface where due to a rise in pH calcium phosphate and calcium fluoride are precipitated.
1322~61 _ 3 _ J.3049 GB-A-l 452 125 (Procter & Gamble) also describes a two-part oral treatment product comprising a first solution containing calcium ions and a second solution containing phosphate ions and fluoride ions, the solutions being applied to the tooth surface sequentially. The respective ions diffuse to the subsurface dental enamel, the ions of the second applied solution coming into contact with those previously deposited and forming a precipitate which is bound to the tooth structure.
There have also been described in the literature various compositions containing both a calcium compound and a fluoride compound and wherein means are provided to inhibit the formation of calcium fluoride; examples are EP-A-40 738 (Richardson-Vicks), GB-A-777 556 (Colgate-Palmolive) and US-A-4 098 435 (Weyn).
GB 1 090 340 (Warner Lambert) discloses a one-part oral composition containing calcium and fluoride ions.
Any calcium fluoride in such compositions will not be freshly precipitated.
GB 1 408 922 (Blendax) and US 4 108 980 (Colgate) disclose compositions comprising calcium, phosphate and fluoride ions for remineralising dental enamel. The disclosed compositions contain such high levels of phosphate that preferential precipitation of solid calcium phosphate phases such as octacalcium phosphate and hydroxyapatite would deplete the liquid phase composition of calcium ions rather than allow calcium fluoride precipitation. Further, any calcium fluoride precipitation would occur slowly due to the presence of large amounts of the crystal growth inhibitor, phosphate.
The present invention provides an oral preparation for inhibiting caries, which comprises as a combined _ 4 _ J.3049 preparation a first composition and a second composition for admixing in the mouth or for admixing immediately prior to introduction into the mouth, wherein the first composition comprises an aqueous solution containing calcium ions, the second composition comprises an aqueous solution containing fluoride ions, the first and second compositions being such that when mixed rapid precipitation of calcium fluoride occurs.
For optimum retention of fluoride in the mouth the ratio of calcium ions to fluoride ions should be stoichiometric (i.e. 1:2).
Rapid precipitation of calcium fluoride is induced by using high concentrations of calcium ions and fluoride ions. Thus, the initial ion product (IP) on mixing the two compositions which is given by the equation:
IP (Ca2+)(F-)2 where (Ca2 ) = calcium ion concentration, and (F ) = fluoride ion concentration should exceed the solubility product of calcium fluoride, 2.85 x 10 11 mol3 dm 9 at 25C, by at least 1000 times.
More preferably, the above ion product should exceed 3 x 10-7 mol3 dm 9.
Rapid precipitation of calcium fluoride is not favoured by low concentrations of calcium ions and fluoride ions. At _ 5 _ J.304g low concentrations of the aforementioned ions a metastable solution may be formed so that precipitation proceeds slowly for many minutes after the ions are mixed. Rapid precipitation is also inhibited by crystal growth inhibitors such as hydrogen phosphate ions (Hpo42 ).
The presence of substances which react with either calcium ions or fluoride ions to produce material having a solubility less than that of calcium fluoride are not advantageous. The presence of substances which reduce the amount of free calcium or fluoride ions before the compositions are mixed are also not advantageous. Examples of such materials are metal ion sequestrants such as EDTA, which react with calcium ions to form complexes, and alumina abrasive particles which bind fluoride.
In preferred embodiments of the invention the composition is in the form of a two-part toothpaste or a two-part mouthwash.
Calcium chloride is used in a preferred embodiment of the invention. Preferably a calcium ion concentration of at least 3.95 mM is used, more preferably at least 8mM.
Calcium ion levels in excess of 0.3M provide no additional benefit and would generally not be used.
Sodium fluoride is used in a preferred embodiment of the invention. A fluoride ion concentration of at least 7.9mM is preferably used, more preferably at least 16mM.
Fluoride ions are preferably less than 0.3M.
One or both Gf the compositions may contain adjuvants. Such adjuvants may include colouring agents, flavours, humectants, abrasives, detergents, preferably nonionic detergents, and the like and other therapeutic agents compatible with calcium or fluoride ions.
- 6 - J.3049 In use the first and second compositions are admixed in the mouth or immediately prior to introduction into the mouth. A delivery system providing for physical separation of the two compositions and for simultaneous or sequential delivery of the compositions may also be used.
The efficacy of the freshly precipitated calcium fluoride in maintaining fluoride ion levels in the mouth is demonstrated by the following experiments.
Procedure The procedure employed for each test was as follows:
(i) a 2ml mouthwash was held in the mouth for one minute and then expectorated. Such mouthwashes consisted of two 1 ml solutions, which were either applied separately or mixed before application.
(ii) saliva samples were collected at regular intervals for several hours after mouthwash application.
(iii) Saliva samples were buffered to pH5 by adding 10 by weight of TISAB buffer and then fluoride activities were measured using a fluoride ion specific electrode (Orion 94-O9).
The following aqueous solutions were used:
a) 0.0526 M sodium chloride b) 0.0526 M calcium chloride and 0.1053 M sodium fluoride mixed immediately prior to application _ 7 _ J.3049 c) as b) but mixed 1.5 hours before application.
d) a suspension of the equivalent concentration of calcium fluoride to that of (c) diluted from a concentrated stock prepared 3 months before application. (Aged calcium fluoride).
Results Figure 1 shows that salivary fluoride levels resulting from application of mouthwashes containing freshly precipitated calcium fluoride are significantly higher than the corresponding values for aged precipitates. The mouthwash containing the most aged calcium fluoride particles (three months old) gave salivary fluoride values only slightly greater than the 'baseline' values measured after application of sodium chloride solution.
The following experiment was performed to demonstrate that a mouthwash containing freshly precipitated calcium fluoride is capable of maintaining fluoride in the mouth at a higher level than a sodium fluoride mouthwash of the same fluoride content.
Procedure The experiment was carried out in a similar manner to that described above using the following aqueous solutions; 0 i) 0.05~6M calcium chloride and 0.1052M sodium fluoxide mixed immediately prior to application ii) 0.0526M sodium fluoride.
i322961 - 8 - J.3049 Results Figure 2 shows that salivary fluoride levels resulting from the application of mouthwashes containing freshly precipitated calcium fluoride are significantly higher than the corresponding values for sodium fluoride.
The invention is illustrated by reference to the following examples. All percentages are by weight.
Mouthwash First composition %
Sodium fluoride 0.11 Sorbitol syrup (70% solution) 15.0 Ethanol 10.0 Nonionic detergent 0.4 Saccharin 0.04 Flavour 0.15 Water to 100 Second composition Calcium chloride dihydrate 0.195 Sorbitol syrup (70% solution) 15.0 Ethanol 10.0 Nonionic detergent 0.4 Saccharin 0.04 Flavour 0.15 Water to 100 Approximately 5 ml of each component are mixed together immediately before use.
_ g _ J.3049 Toothpaste First composition %
Sodium fluoride 0.44 Abrasive silica 14.0 Thickening silica 8.0 Sorbitol syrup (70~ solution) 50.0 Sodium carboxymethylcellulose 0.65 Nonionic detergent 1.5 Flavour 1.0 Saccharin 0.1 Titanium dioxide 1.0 Water to 100 adjust pH to 7.0-7.5 with NaOH.
2~
Second composition %
Calcium chloride dihydrate 0.78 Abrasive silica 14.0 Thickening silica 8.0 Sorbitol syrup ~70% solution~ 50.0 SCMC 0.65 Nonionic detergent 1.5 Flavour 1.0 Saccharin 0.1 Titanium dioxide 1.0 Water to 100 adjust pH to 7.0-7.5 with NaOH.
to be mixed in equal proportions in use.
- 10 - J.3049 Toothpaste-mouthwash combinations are also within the scope of the invention. One such combination can be achieved by applying the first composition, 1 ml of a mouthwash of composition s Sodium fluoride 0.44 Sorbitol syrup (70% solution)15.0 Ethanol 10.0 Nonionic detergent 0.4 Saccharin 0.04 Flavour 0.15 Water to 100.0 and then immediately brushing with the second composition of Example 2.
The oral product of the invention may also be incorporated in other oral preparations or formulations such as dual composition lozenges, sweets and chewing gum.
This invention relates to oral products, more particularly oral hygiene products which are effective to combat dental caries.
It is well known to include water-soluble fluorine-containing salts, for example sodium fluoride or sodium monofluorophosphate, in oral products, especially mouthwashes and toothpastes, and that by regular use of such products the incidence of dental caries can be reduced. It is believed that the fluoride ion or monofluorophosphate ion, interacts with the tooth substance to increase its resistance to acid attack and to aid repair of carious enamel. However, the opportunity for this efficacious interaction to occur is short-lived because the oral fluoride level falls off rapidly after use of a mouthwash or toothpaste.
There have been attempts in the past to provide means for maintaining a certain concentration of fluoride ions in ~322961 - 2 - J.3049 the mouth over a longer period. These have included proposals for locating a fluoride ion source in the mouth, for example as part of an orthodontic appliance.
The Applicants have investigated the possibility of depositing particles of a fluoride ion-releasing material in the mouth and have discovered that surprising results are achieved through the use of particles of freshly precipitated calcium fluoride, as is more particularly described hereinafter.
It is already known to treat teeth to provide anticaries protection with compositions containing calcium ions and fluoride ions. Such compositions are described in EP-A-89 136 (Procter & Gamble) and they comprise a calcium ion source, a fluoride ion source and a calcium sequestering agent possessing specific solubility and binding properties to control the precipitation of calcium fluoride. The calcium-sequestering agent present in these compositions has a stability constant sufficient to inhibit uncontrolled and rapid precipitation of calcium fluoride.
In US-A-4 080 440 (DiGuilo et al) there is described a two-part product for example mouthwash or toothpaste, for remineralising demineralised tooth enamel, consisting of a first solution containing calcium ions and a second solution containing phosphate ions and optionally fluoride ions, which solutions when mixed together form a metastable solution having a pH of about 4 or below. The metastable solution is applied to the tooth surface within 5 minutes of its formation. The ions diffuse into the demineralised subsurface where due to a rise in pH calcium phosphate and calcium fluoride are precipitated.
1322~61 _ 3 _ J.3049 GB-A-l 452 125 (Procter & Gamble) also describes a two-part oral treatment product comprising a first solution containing calcium ions and a second solution containing phosphate ions and fluoride ions, the solutions being applied to the tooth surface sequentially. The respective ions diffuse to the subsurface dental enamel, the ions of the second applied solution coming into contact with those previously deposited and forming a precipitate which is bound to the tooth structure.
There have also been described in the literature various compositions containing both a calcium compound and a fluoride compound and wherein means are provided to inhibit the formation of calcium fluoride; examples are EP-A-40 738 (Richardson-Vicks), GB-A-777 556 (Colgate-Palmolive) and US-A-4 098 435 (Weyn).
GB 1 090 340 (Warner Lambert) discloses a one-part oral composition containing calcium and fluoride ions.
Any calcium fluoride in such compositions will not be freshly precipitated.
GB 1 408 922 (Blendax) and US 4 108 980 (Colgate) disclose compositions comprising calcium, phosphate and fluoride ions for remineralising dental enamel. The disclosed compositions contain such high levels of phosphate that preferential precipitation of solid calcium phosphate phases such as octacalcium phosphate and hydroxyapatite would deplete the liquid phase composition of calcium ions rather than allow calcium fluoride precipitation. Further, any calcium fluoride precipitation would occur slowly due to the presence of large amounts of the crystal growth inhibitor, phosphate.
The present invention provides an oral preparation for inhibiting caries, which comprises as a combined _ 4 _ J.3049 preparation a first composition and a second composition for admixing in the mouth or for admixing immediately prior to introduction into the mouth, wherein the first composition comprises an aqueous solution containing calcium ions, the second composition comprises an aqueous solution containing fluoride ions, the first and second compositions being such that when mixed rapid precipitation of calcium fluoride occurs.
For optimum retention of fluoride in the mouth the ratio of calcium ions to fluoride ions should be stoichiometric (i.e. 1:2).
Rapid precipitation of calcium fluoride is induced by using high concentrations of calcium ions and fluoride ions. Thus, the initial ion product (IP) on mixing the two compositions which is given by the equation:
IP (Ca2+)(F-)2 where (Ca2 ) = calcium ion concentration, and (F ) = fluoride ion concentration should exceed the solubility product of calcium fluoride, 2.85 x 10 11 mol3 dm 9 at 25C, by at least 1000 times.
More preferably, the above ion product should exceed 3 x 10-7 mol3 dm 9.
Rapid precipitation of calcium fluoride is not favoured by low concentrations of calcium ions and fluoride ions. At _ 5 _ J.304g low concentrations of the aforementioned ions a metastable solution may be formed so that precipitation proceeds slowly for many minutes after the ions are mixed. Rapid precipitation is also inhibited by crystal growth inhibitors such as hydrogen phosphate ions (Hpo42 ).
The presence of substances which react with either calcium ions or fluoride ions to produce material having a solubility less than that of calcium fluoride are not advantageous. The presence of substances which reduce the amount of free calcium or fluoride ions before the compositions are mixed are also not advantageous. Examples of such materials are metal ion sequestrants such as EDTA, which react with calcium ions to form complexes, and alumina abrasive particles which bind fluoride.
In preferred embodiments of the invention the composition is in the form of a two-part toothpaste or a two-part mouthwash.
Calcium chloride is used in a preferred embodiment of the invention. Preferably a calcium ion concentration of at least 3.95 mM is used, more preferably at least 8mM.
Calcium ion levels in excess of 0.3M provide no additional benefit and would generally not be used.
Sodium fluoride is used in a preferred embodiment of the invention. A fluoride ion concentration of at least 7.9mM is preferably used, more preferably at least 16mM.
Fluoride ions are preferably less than 0.3M.
One or both Gf the compositions may contain adjuvants. Such adjuvants may include colouring agents, flavours, humectants, abrasives, detergents, preferably nonionic detergents, and the like and other therapeutic agents compatible with calcium or fluoride ions.
- 6 - J.3049 In use the first and second compositions are admixed in the mouth or immediately prior to introduction into the mouth. A delivery system providing for physical separation of the two compositions and for simultaneous or sequential delivery of the compositions may also be used.
The efficacy of the freshly precipitated calcium fluoride in maintaining fluoride ion levels in the mouth is demonstrated by the following experiments.
Procedure The procedure employed for each test was as follows:
(i) a 2ml mouthwash was held in the mouth for one minute and then expectorated. Such mouthwashes consisted of two 1 ml solutions, which were either applied separately or mixed before application.
(ii) saliva samples were collected at regular intervals for several hours after mouthwash application.
(iii) Saliva samples were buffered to pH5 by adding 10 by weight of TISAB buffer and then fluoride activities were measured using a fluoride ion specific electrode (Orion 94-O9).
The following aqueous solutions were used:
a) 0.0526 M sodium chloride b) 0.0526 M calcium chloride and 0.1053 M sodium fluoride mixed immediately prior to application _ 7 _ J.3049 c) as b) but mixed 1.5 hours before application.
d) a suspension of the equivalent concentration of calcium fluoride to that of (c) diluted from a concentrated stock prepared 3 months before application. (Aged calcium fluoride).
Results Figure 1 shows that salivary fluoride levels resulting from application of mouthwashes containing freshly precipitated calcium fluoride are significantly higher than the corresponding values for aged precipitates. The mouthwash containing the most aged calcium fluoride particles (three months old) gave salivary fluoride values only slightly greater than the 'baseline' values measured after application of sodium chloride solution.
The following experiment was performed to demonstrate that a mouthwash containing freshly precipitated calcium fluoride is capable of maintaining fluoride in the mouth at a higher level than a sodium fluoride mouthwash of the same fluoride content.
Procedure The experiment was carried out in a similar manner to that described above using the following aqueous solutions; 0 i) 0.05~6M calcium chloride and 0.1052M sodium fluoxide mixed immediately prior to application ii) 0.0526M sodium fluoride.
i322961 - 8 - J.3049 Results Figure 2 shows that salivary fluoride levels resulting from the application of mouthwashes containing freshly precipitated calcium fluoride are significantly higher than the corresponding values for sodium fluoride.
The invention is illustrated by reference to the following examples. All percentages are by weight.
Mouthwash First composition %
Sodium fluoride 0.11 Sorbitol syrup (70% solution) 15.0 Ethanol 10.0 Nonionic detergent 0.4 Saccharin 0.04 Flavour 0.15 Water to 100 Second composition Calcium chloride dihydrate 0.195 Sorbitol syrup (70% solution) 15.0 Ethanol 10.0 Nonionic detergent 0.4 Saccharin 0.04 Flavour 0.15 Water to 100 Approximately 5 ml of each component are mixed together immediately before use.
_ g _ J.3049 Toothpaste First composition %
Sodium fluoride 0.44 Abrasive silica 14.0 Thickening silica 8.0 Sorbitol syrup (70~ solution) 50.0 Sodium carboxymethylcellulose 0.65 Nonionic detergent 1.5 Flavour 1.0 Saccharin 0.1 Titanium dioxide 1.0 Water to 100 adjust pH to 7.0-7.5 with NaOH.
2~
Second composition %
Calcium chloride dihydrate 0.78 Abrasive silica 14.0 Thickening silica 8.0 Sorbitol syrup ~70% solution~ 50.0 SCMC 0.65 Nonionic detergent 1.5 Flavour 1.0 Saccharin 0.1 Titanium dioxide 1.0 Water to 100 adjust pH to 7.0-7.5 with NaOH.
to be mixed in equal proportions in use.
- 10 - J.3049 Toothpaste-mouthwash combinations are also within the scope of the invention. One such combination can be achieved by applying the first composition, 1 ml of a mouthwash of composition s Sodium fluoride 0.44 Sorbitol syrup (70% solution)15.0 Ethanol 10.0 Nonionic detergent 0.4 Saccharin 0.04 Flavour 0.15 Water to 100.0 and then immediately brushing with the second composition of Example 2.
The oral product of the invention may also be incorporated in other oral preparations or formulations such as dual composition lozenges, sweets and chewing gum.
Claims (9)
1. An oral preparation for inhibiting caries, which comprises as a combined preparation a first composition and a second composition for admixing in the mouth or for admixing immediately prior to introduction into the mouth, wherein the first composition contains a source of calcium ions, the second composition contains a source of fluoride ions, the first and second compositions being such that when mixed rapid precipitation of calcium fluoride occurs;
and wherein the ion product (IP) of the calcium ions and fluoride ions as hereinbefore defined exceeds 3x10-8 mol3 dm-9 on mixing.
and wherein the ion product (IP) of the calcium ions and fluoride ions as hereinbefore defined exceeds 3x10-8 mol3 dm-9 on mixing.
2. A preparation as claimed in Claim 1 wherein the calcium salt is calcium chloride.
3. A preparation as claimed in Claim 1 wherein the fluoride salt is sodium fluoride.
4. A preparation as claimed in Claim 1 wherein the compositions are in the form of a two-part mouthwash.
5. A preparation as claimed in Claim 1 wherein the compositions are in the form of a two-part toothpaste.
6. The use for inhibiting dental caries of a first composition containing a source of calcium ions from calcium chloride and a second composition containing a source of fluoride ions from sodium fluoride, said compositions being admixed thereby forming an oral preparation of calcium fluoride, in which said oral preparation is introduced into a mouth and said compositions are admixed outside the dentulous mouth but less than 1.5 hours prior to said introduction into the mouth.
7. The use as claimed in claim 6 wherein the ion product (IP) of the calcium ions and fluoride ions as hereinbefore defined exceeds 3 x 10-8 mol3 dm-9 on mixing.
8. The use as claimed in claim 6 wherein the compositions are in the form of a two-part mouthwash.
9. The use as claimed in claim 6 wherein the compositions are in the form of a two-part toothpaste.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868623643A GB8623643D0 (en) | 1986-10-02 | 1986-10-02 | Oral products |
| GB8623643 | 1986-10-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1322961C true CA1322961C (en) | 1993-10-12 |
Family
ID=10605135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000547991A Expired - Fee Related CA1322961C (en) | 1986-10-02 | 1987-09-28 | Oral composition |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5045305A (en) |
| EP (1) | EP0263638B1 (en) |
| JP (1) | JPH0637382B2 (en) |
| AT (1) | ATE71282T1 (en) |
| AU (1) | AU597428B2 (en) |
| CA (1) | CA1322961C (en) |
| DE (1) | DE3775876D1 (en) |
| ES (1) | ES2038670T3 (en) |
| GB (1) | GB8623643D0 (en) |
| IN (1) | IN166119B (en) |
| PH (1) | PH25089A (en) |
| ZA (1) | ZA877366B (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS646213A (en) * | 1987-06-27 | 1989-01-10 | Sangi Kk | Composition for preventing denting caries |
| EP0985407A1 (en) * | 1989-03-13 | 2000-03-15 | American Dental Association Health Foundation | Fluoride containing mouth rinses, dentifrices, gels, and chewable tablets |
| US5049375A (en) * | 1989-05-31 | 1991-09-17 | Kao Corporation | Oral compositions containing colloidal fluoride |
| AU644618B2 (en) * | 1989-12-28 | 1993-12-16 | G-C Shika Kogyo Kabushiki Kaisha | Odontotherapeutical materials |
| GB9018836D0 (en) * | 1990-08-29 | 1990-10-10 | Neirinckx Rudi | Desensitising dental composition |
| US5476647A (en) * | 1993-09-13 | 1995-12-19 | American Dental Association Health Foundation | Complex calcium and fluoride containing mouth rinses, dentifrices, and chewable tablets |
| EP0719130B1 (en) * | 1993-09-13 | 1998-11-25 | American Dental Association Health Foundation | Complex calcium and fluoride containing mouth rinses, dentifrices, and chewable tablets |
| CA2209556A1 (en) * | 1995-01-06 | 1996-07-11 | American Dental Association Health Foundation | Control of calcium fluoride formation in mouth rinses, dentifrices and gels |
| US5605675A (en) * | 1995-06-06 | 1997-02-25 | Enamelon Inc. | Processes and compositions for remineralization and prevention of demineralization of dental enamel |
| US6230935B1 (en) | 1995-07-28 | 2001-05-15 | Colgate-Palmolive Company | Dual chamber pump dispenser |
| US5603922A (en) * | 1995-08-08 | 1997-02-18 | Enamelon Inc. | Processes and compositions for the remineralization of teeth |
| US5723107A (en) * | 1995-11-02 | 1998-03-03 | Colgate Palmolive Company | Dual component dentifrice composition for fluoridating teeth |
| US5775386A (en) * | 1996-06-13 | 1998-07-07 | Colgate-Palmolive Company | Apparatus and process for filling plural chamber container with flowable materials |
| US6159448A (en) * | 1996-09-27 | 2000-12-12 | Enamelon, Inc. | Products and methods for the remineralization and prevention of demineralization of teeth |
| AU4083597A (en) | 1996-09-27 | 1998-04-17 | Enamelon, Inc. | Improved products and methods for the remineralization and prevention of demineralization of teeth |
| US5782384A (en) * | 1996-11-05 | 1998-07-21 | Colgate-Palmolive | Aligned web in a container |
| US5849241A (en) * | 1996-12-20 | 1998-12-15 | Colgate-Palmolive Company | Multichamber container with expanded interior walls |
| US6159449A (en) * | 1997-04-03 | 2000-12-12 | Enamelon, Inc. | Dentifrice products and methods for remineralizing and/or mineralizing teeth |
| US5941420A (en) * | 1997-08-06 | 1999-08-24 | Colgate-Palmolive Company | Multichamber container dispensing orifices |
| WO2000062748A1 (en) * | 1999-04-15 | 2000-10-26 | Unilever N.V. | Oral care system containing sunflower oil |
| EP1603525B1 (en) * | 2002-12-27 | 2009-04-01 | Kao Corporation | Oral preparation system |
| CN1320879C (en) * | 2002-12-27 | 2007-06-13 | 花王株式会社 | Oral preparation system |
| US6669929B1 (en) | 2002-12-30 | 2003-12-30 | Colgate Palmolive Company | Dentifrice containing functional film flakes |
| US20050210615A1 (en) * | 2004-03-29 | 2005-09-29 | Ramachandra Shastry | Oral care method |
| US9011823B2 (en) * | 2005-02-01 | 2015-04-21 | Ada Foundation | Enhanced anti-carious dentifrices, rinses, lozenges, candies and chewing gums and methods of using same |
| GB0505760D0 (en) * | 2005-03-21 | 2005-04-27 | Glaxo Group Ltd | Novel composition |
| JP2008533183A (en) * | 2005-03-21 | 2008-08-21 | グラクソ グループ リミテッド | Dentifrice composition free of alkyl sulfate and orthophosphate, comprising fluoride source and silica tooth polish |
| JP2007099632A (en) * | 2005-09-30 | 2007-04-19 | Sunstar Inc | Method for promoting recalcification of tooth |
| US20070148213A1 (en) * | 2005-12-22 | 2007-06-28 | Sayed Ibrahim | Film containing compositions |
| US8282298B2 (en) | 2008-06-26 | 2012-10-09 | Colgate-Palmolive Company | Oral care implement |
| TWI462709B (en) | 2010-03-31 | 2014-12-01 | Colgate Palmolive Co | Oral care implement with rapid flavor release |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL202309A (en) * | 1954-11-24 | |||
| DE1492247A1 (en) * | 1964-03-20 | 1969-11-06 | Warner Lambert Pharmaceutical | Process for re-hardening tooth enamel and suitable dental care products |
| US3711604A (en) * | 1971-07-19 | 1973-01-16 | Colgate Palmolive Co | Fluoride containing transparent dentifrice |
| GB1408922A (en) * | 1972-02-02 | 1975-10-08 | Blendax Werke Schneider Co | Process and composition for the remineralisation and prevention of demineralisation of human teeth |
| AU6104973A (en) * | 1972-10-13 | 1975-04-10 | Procter & Gamble | Remineralization of dental enamel |
| US4108980A (en) * | 1973-01-11 | 1978-08-22 | Colgate-Palmolive Company | Process of preparing materials having calcium and phosphate components |
| US4080440A (en) * | 1974-12-13 | 1978-03-21 | The Procter & Gamble Company | Method for remineralizing tooth enamel |
| US4083955A (en) * | 1975-04-02 | 1978-04-11 | The Procter & Gamble Company | Processes and compositions for remineralization of dental enamel |
| US4098435A (en) * | 1976-08-16 | 1978-07-04 | Colgate-Palmolive Company | Stabilized dentrifice containing initially physically separated normally reactive components |
| US4211341A (en) * | 1976-08-16 | 1980-07-08 | Colgate-Palmolive Company | Dispensing container of stabilized extrudable dentifrice containing normally chemically reactive components |
| US4283385A (en) * | 1980-05-09 | 1981-08-11 | Richardson-Merrell Inc. | Dentifrices with improved soluble fluoride availability |
| US4357318A (en) * | 1981-07-31 | 1982-11-02 | Richardson-Vicks Inc. | Dentifrices with improved soluble fluoride availability |
| JPS58219107A (en) * | 1982-03-10 | 1983-12-20 | ザ・プロクタ−・エンド・ギヤンブル・カンパニ− | Oral sanitary product |
| GR77131B (en) * | 1982-03-10 | 1984-09-07 | Procter & Gamble | |
| NO155225C (en) * | 1984-10-09 | 1987-03-04 | Gunnar Roella | DENTAL TREATMENT PREPARATION CONTAINING FLUORIDIONS. |
| GB8510310D0 (en) * | 1985-04-23 | 1985-05-30 | Causton B E | Dental treatment |
| GB8527962D0 (en) * | 1985-11-13 | 1985-12-18 | Neirinckx R D | Desensitizing dental composition |
| PH23397A (en) * | 1985-12-11 | 1989-07-26 | Unilever Nv | Oral hygiene product |
-
1986
- 1986-10-02 GB GB868623643A patent/GB8623643D0/en active Pending
-
1987
- 1987-09-25 PH PH35854A patent/PH25089A/en unknown
- 1987-09-28 CA CA000547991A patent/CA1322961C/en not_active Expired - Fee Related
- 1987-09-29 AU AU79062/87A patent/AU597428B2/en not_active Ceased
- 1987-09-30 ES ES198787308657T patent/ES2038670T3/en not_active Expired - Lifetime
- 1987-09-30 DE DE8787308657T patent/DE3775876D1/en not_active Expired - Lifetime
- 1987-09-30 AT AT87308657T patent/ATE71282T1/en not_active IP Right Cessation
- 1987-09-30 EP EP19870308657 patent/EP0263638B1/en not_active Expired - Lifetime
- 1987-09-30 ZA ZA877366A patent/ZA877366B/en unknown
- 1987-10-01 IN IN308/BOM/87A patent/IN166119B/en unknown
- 1987-10-02 JP JP62249680A patent/JPH0637382B2/en not_active Expired - Lifetime
-
1989
- 1989-12-11 US US07/449,489 patent/US5045305A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63101312A (en) | 1988-05-06 |
| EP0263638A3 (en) | 1989-04-26 |
| AU7906287A (en) | 1988-04-14 |
| EP0263638B1 (en) | 1992-01-08 |
| AU597428B2 (en) | 1990-05-31 |
| ZA877366B (en) | 1989-05-30 |
| US5045305A (en) | 1991-09-03 |
| IN166119B (en) | 1990-03-17 |
| ATE71282T1 (en) | 1992-01-15 |
| ES2038670T3 (en) | 1993-08-01 |
| PH25089A (en) | 1991-02-19 |
| JPH0637382B2 (en) | 1994-05-18 |
| EP0263638A2 (en) | 1988-04-13 |
| GB8623643D0 (en) | 1986-11-05 |
| DE3775876D1 (en) | 1992-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1322961C (en) | Oral composition | |
| EP0075446B1 (en) | Anticaries composition | |
| JPS5846483B2 (en) | Oral composition | |
| CA2747747C (en) | Composition and method for reducing demineralization of teeth | |
| JPS61165317A (en) | Oral sanitary composition | |
| GB2216005A (en) | Dental compositions containing stannous ions | |
| FR2508796A1 (en) | TOOTHING COMPOSITION HAVING AN ACTIVITY AGAINST CARRY AND CAPABLE OF AT LEAST PARTIALLY RECONSTITUTING THE CAREOUS PARTS OF TEETH | |
| JPH0222216A (en) | Oral composition | |
| US4927625A (en) | Toothpastes | |
| Van Strijp et al. | In situ fluoride retention in enamel and dentine after the use of an amine fluoride dentifrice and amine fluoride/sodium fluoride mouthrinse | |
| Sullivan et al. | In vivo detection of calcium from dicalcium phosphate dihydrate dentifrices in demineralized human enamel and plaque | |
| EP0129201A2 (en) | Oral hygiene compositions | |
| US3666855A (en) | Oral compositions and methods for retarding dental caries and calculus | |
| US5068100A (en) | Anticalculus compositions | |
| EP0265186A2 (en) | Anticalculus compositions | |
| US4978522A (en) | Oral compositions | |
| JPS5846484B2 (en) | Oral composition | |
| EP0000256B2 (en) | The use of a lanthanum salt for the manufacture of an aqueous composition for cleaning teeth | |
| AU2005244272A1 (en) | Composition, comprising hydrofluoric acid, for inhibiting dental erosion | |
| US4990328A (en) | Anticalculus compositions | |
| Hirose et al. | Fluoride retention in saliva following toothbrushing using different types of fluoridated dentifrices containing 1500 ppm F of NaF and MFP | |
| JPH0669947B2 (en) | Oral hygiene composition | |
| JPS63190825A (en) | Anticalculus composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |